Literature DB >> 6274387

Purification of rabbit brain endooligopeptidases and preparation of anti-enzyme antibodies.

K M Carvalho, A C Camargo.   

Abstract

Endooligopeptidase A was purified approximately 3 000-fold and endooligopeptidase B approximately 1200-fold from the 25 000g supernatant fraction of rabbit brain homogenate. The purified enzymes were homogeneous on the basis of acrylamide gel electrophoresis under denaturing and nondenaturing conditions, isoelectric focusing, immunochemical criteria, and specific activities of the elution profile of gel filtration on Sephadex G-100. The only peptide bond cleaved by endooligopeptidase A in bradykinin, Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-Arg9, is Phe5-Ser6, whereas endooligopeptidase B hydrolyzes the Pro7-Phe8 peptide bond of bradykinin and the Pro3-Gly4 bond of des-Phe8-Arg9-bradykinin. The specific activity of the homogeneous enzymes using bradykinin as substrate was 1087 nmol min-1 mg-1 for endooligopeptidase A and 292 nmol min-1 mg-1 for endooligopeptidase B. Gel filtration suggested molecular weights of 75 000 and 68 000 for endooligopeptidases A and B, respectively. Sodium dodecyl sulfate gel electrophoresis suggested that each endooligopeptidase consisted of a single polypeptide chain with molecular weights of 74 000 and 69 000 for the A and B enzymes, respectively. Purified endooligopeptidase A or B injected into goats produces monospecific antisera directed against each enzyme. The antibody prepared against each endooligopeptidase did not react with or inhibit the activity of the other enzyme.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274387     DOI: 10.1021/bi00528a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Purification and characterization of human brain prolyl endopeptidase.

Authors:  S Kalwant; A G Porter
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Distinction between endo-oligopeptidase A (EC 3.4.22.19) and soluble metalloendopeptidase (EC 3.4.24.15)

Authors:  A C Camargo
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase.

Authors:  A C Camargo; M D Gomes; A P Reichl; E S Ferro; S Jacchieri; I Y Hirata; L Juliano
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 4.  NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness.

Authors:  Nicholas J Bradshaw; Mirian A F Hayashi
Journal:  Cell Mol Life Sci       Date:  2016-10-14       Impact factor: 9.261

5.  Enkephalin is liberated from metorphamide and dynorphin A1-8 by endo-oligopeptidase A, but not by metalloendopeptidase EC 3.4.24.15.

Authors:  O Toffoletto; K M Metters; E B Oliveira; A C Camargo; J Rossier
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

Review 6.  Pituitary endopeptidases.

Authors:  M Orlowski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides.

Authors:  M Orlowski; S Reznik; J Ayala; A R Pierotti
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

8.  Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.

Authors:  E A DelBel; A P Padovan; G J Padovan; O Z Sellinger; A R Martins
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

9.  Screening, purification, and characterization of an extracellular prolyl oligopeptidase from Coprinopsis clastophylla.

Authors:  Jen-Tao Chen; Mei-Li Chao; Chiou-Yen Wen; Wen-Shen Chu
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

10.  Human thimet oligopeptidase.

Authors:  P M Dando; M A Brown; A J Barrett
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.